The Reagan-Udall Foundation for the FDA, in cooperation with the Food and Drug Administration, will host a public webinar continuing discussion of the Food Traceability Rule.

The Reagan-Udall Foundation for the FDA, in cooperation with the Food and Drug Administration, will convene a hybrid public meeting to gather input on the clinical use and safety concerns associated with orally ingestible unapproved prescription drug products containing fluoride for use in children.

Celebrating outstanding achievement in regulatory science

The Reagan-Udall Foundation for the FDA, in collaboration with the Food and Drug Administration (FDA), hosted a virtual, public workshop to explore opportunities to optimize therapeutic development to address primary mitochondrial diseases.

Explore FDA draft guidance in this Real-World Evidence Webinar hosted by the Reagan-Udall Foundation and FDA on Nov. 22, 2024—focusing on integrating randomized controlled trials into routine clinical practice for drugs and biologics.

On October 30, 2024, we held a one-hour session on IMEDS, a flagship program of the Regan-Udall Foundation for the FDA.

On October 7, we hosted a virtual public meeting to hear insights on the Final Rule on Requirements for Additional Traceability Records from both FDA leadership and other experts from across food industry sectors.